SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-17-000189
Filing Date
2017-11-20
Accepted
2017-11-20 16:33:41
Documents
26
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 sangui10qvedgar5.htm 10-Q 205002
2 exhibit3101.htm EX-31 8107
3 exhibit3102.htm EX-31 8668
4 exhibit3201.htm EX-32 4220
  Complete submission text file 0001551163-17-000189.txt   712143

Data Files

Seq Description Document Type Size
5 sgbi-20170930.xml EX-101.INS 42630
6 sgbi-20170930.xsd EX-101.SCH 7140
7 sgbi-20170930_cal.xml EX-101.CAL 17015
8 sgbi-20170930_def.xml EX-101.DEF 4980
9 sgbi-20170930_lab.xml EX-101.LAB 64691
10 sgbi-20170930_pre.xml EX-101.PRE 48339
Mailing Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025
Business Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025 011 49 1607 412717
SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)

IRS No.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-29233 | Film No.: 171214150
SIC: 2834 Pharmaceutical Preparations